Clinical Trial Update: Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis

View source ↗

Summary

A prospective longitudinal study evaluating the Syde digital endpoint in patients with Multiple Sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: SYSNAV | Conditions: Multiple Sclerosis | Status: TERMINATED